Carregant...
Egr-ly awaiting a “personalized medicine” approach to treat scleroderma
Scleroderma, an autoimmune disorder characterized by skin and organ fibrosis, has no treatment. Although over the past decade valuable insights into the molecular mechanisms underlying scleroderma have been generated, results in clinical trials have been disappointing. This issue is likely to arise...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Netherlands
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3368023/ https://ncbi.nlm.nih.gov/pubmed/22350706 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12079-012-0160-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|